ARCHIVES

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Seeks 150 Advocates For Advice On Plans, Policies.

March 2, 2001

ASCO Recognizes 15 for Leadership in Clinical Oncology, Updates Genetic Testing Recommendations

May 23, 2003

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

PROPOC Study Analyses Six Cancer DRGs

January 17, 1986

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989